FAQ Directory: HEDIS

Filter Results
  • Save
    Save your favorite pages and receive notifications whenever they’re updated. You will be prompted to log in to your NCQA account.
  • Email
    Share this page with a friend or colleague by Email. We do not share your information with third parties.
  • Print this page.

8.31.2026 HEDIS MY 2028 Measure Specification Structure Changes: Revised Narrative Language and Measure Interpretation What should organizations do if the updated narrative language appears different from how the organization currently implements a measure?

The updated specification structure is intended to organize and align information with its FHIR-based digital equivalent and is not intended to change current reporting expectations. Organizations should continue following existing HEDIS reporting guidance and audit requirements.

If questions arise regarding a specific measure or implementation scenario, NCQA welcomes questions or comments through My NCQA, utilizing the MY 2028 Preview: Measure Specification Enhancements option within the 'General Content Area' dropdown under the HEDIS option within the 'Product/Program Type' dropdown.

HEDIS MY 2028

8.31.2026 HEDIS MY 2028 Measure Specification Structure Changes: What Measures Will I See in This Format NCQA is updating the structure of the narrative measure specifications for a subset of measures for HEDIS MY 2028, what measures are in this subset?

NCQA is finalizing the subset of measures that will be released in the updated format for MY 2028. Additional information will be provided before publication of the HEDIS MY 2028 Volume 2 specifications.

HEDIS MY 2028

8.31.2026 HEDIS MY 2028 Measure Specification Structure Changes: What Not to Expect What aspects of HEDIS reporting remain the same?

The specification structure updates do not change:
•    Measure intent.
•    Calculation logic.
•    Reporting requirements.
•    Data element reporting requirements.
•    Audit expectations.
•    Existing workflows and operational processes.
•    Performance rates or trending assumptions.

Organizations can continue using the same codes, data sources, timing guidance, workflows and audit practices they rely on today.

HEDIS MY 2028

8.31.2026 HEDIS® MY 2028 Measure Specification Structure Changes: The Why Why is NCQA updating the structure of the narrative measure specifications for a subset of HEDIS MY 2028 measures?

NCQA is continuing its efforts to support organizations in the transition to digital quality measurement. The MY 2028 updates are non-substantive, structural changes to select narrative measure specifications. These updates create a connection between the narrative specification and its FHIR®-based digital equivalent while maintaining current reporting and audit practices. Organizations that are not pursuing Digital HEDIS can continue their current reporting approach without modification.

HEDIS MY 2028

8.31.2026 HEDIS MY 2028 Measure Specification Structure Changes: Any Changes to Systems or Reporting Processes Will systems, workflows or reporting processes need to be updated because of these changes?

No. Organizations can continue using their current systems, reporting processes, workflows and operational practices. The updates do not introduce new reporting requirements or require changes to existing implementations. The updated structure is designed to help organizations that choose to pursue digital quality measurement in the future, while preserving current reporting expectations.

HEDIS MY 2028

8.14.2026 PCS Questions Do answers from the Policy Clarification Support system have an expiration date?

Organizations may not use PCS responses that are over 3 years old. Questions that relate directly to a measure specification or general guideline that was revised from a previous measurement year should be resubmitted rather than using the previous answer in PCS.

HEDIS MY 2027

7.15.2026 Changes to Maternity Billing With the maternity care service coding changes taking effect in 2027, does NCQA plan to update its maternity-related measures to accommodate these changes?

Yes, changes to the Prenatal and Postpartum Care measure will be included in HEDIS MY 2027 Volume 2 (scheduled for release August 3, 2026). Consistent with the planned changes for maternity care billing, evaluation and management codes in combination with a TH modifier will meet criteria for prenatal and postpartum care. Codes no longer used for maternity care services will not be removed from the measure until the lookback period has passed. We anticipate additional codes may be added to the measure in the Technical Update release after CPT releases the full code set publication in the fall of 2026. 

HEDIS MY 2027

7.15.2026 Portable HbA1c Device Testing for the Glycemic Status Assessment for Patients With Diabetes (GSD) measure Does NCQA approve the use of portable point-of-care HbA1c devices and are HbA1c results obtained from these devices acceptable for reporting?

HbA1c results obtained from portable point-of-care devices are acceptable when the test is performed by clinical staff, regardless of whether the test is conducted at home or in a provider office. Self-collected samples are also acceptable if sent to a laboratory or provider’s office for analysis and result calculation. Self-administered tests reported by the member do not meet criteria (General Guideline: Self-Collected Samples).

HEDIS MY 2026

7.15.2026 Blood-based testing for the Colorectal Cancer Screening (COL-E) measure Does NCQA include sRNA stool or blood test as an acceptable form of screening for Colorectal Cancer Screening (COL-E) measure?

No. At this time, these tests are not included in the COL-E measure or its value sets and we cannot predict if or when sRNA type tests will be added.

NCQA relies on a broad body of scientific evidence and guidance from multiple independent clinical guideline bodies when developing and updating quality measures. These include, but are not limited to, recommendations from the U.S. Preventive Services Task Force (USPSTF), as well as other national organizations. NCQA monitors emerging screening concepts and reviews evidence as it becomes available through its established measure development processes.

Because of this, while some tests may receive FDA authorization and are covered under certain CMS policies, they are not automatically included in our measures. NCQA will continue to review the guidelines and scientific literature, and communicate changes if they are made.

HEDIS MY 2026

7.15.2026 Source System of Record (SSoR) Reporting and Hierarchy Guidance for ECDS Measures How should plans approach SSoR category reporting and source hierarchy/prioritization for ECDS measures in MY 2026?

Reporting by SSoR category (e.g., EMR, HIE, case management, administrative) was sunset for MY 2026 and measure results no longer need to be attributed to an SSoR category when reported.

Additionally, HEDIS MY 2026 does not include guidance on hierarchy for ECDS reported measures. The hierarchy should not change the performance result, just the data source contributing the information.

NCQA is not prescriptive about how source prioritization is programmed into the measure logic. It is up to the plan to determine how sources are prioritized when calculating results to avoid double counting and it should be done consistently across measures.

HEDIS MY 2026

4.15.2026 HEDIS® MY 2026 Technical Update Value Set Directory Re-Release Did NCQA release an updated Value Set Directory for HEDIS MY 2026 Volume 2 in April, and are there targeted changes?

Yes, NCQA recently identified and corrected an internal administrative error related to the Osteoporosis Management in Women (OMW) measure.

As part of NCQA's routine oversight process for all measures, certain value sets related to quantitative ultrasound (QUS) were prematurely removed from the OMW measure specifications. They have since been reinstated for measurement year 2026.

The value sets are now undergoing further assessment as part of a broader examination of the Osteoporosis measure bundle, consistent with NCQA’s ongoing efforts to ensure measures are aligned with scientifically sound and methodologically credible standards of care. Any future updates to value sets will be made and communicated in accordance with established notification requirements.

NCQA regrets any confusion this may have caused.

The updated HEDIS MY 2026 Value Set Directory was made available on April 15 to all purchasers of HEDIS MY 2026 Volume 2 publication through the My Downloads section of My NCQA. The April version of the Value Set Directory must be used for HEDIS MY 2026 reporting.

HEDIS MY 2026

4.15.2026 Pharmacotherapy for Opioid Use Disorder (POD): Buprenorphine Injections Days Supply Days supply is required to calculate the Pharmacotherapy for Opioid Use Disorder (POD) measure. For OUD dispensing events identified using a medication list, the days supply in the pharmacy data is used. If days supply is not available in the pharmacy data then the days supply listed for the corresponding value set is used.
In the MY 2026 Technical Update a new value set was added for buprenorphine injections, resulting in two value sets with two different days supply. What days supply should be used for buprenorphine injections when pharmacy data does not include that information?

For buprenorphine injection dispensing events identified using a medication list, if the days supply is not available in the pharmacy data, count as a 31 days supply.

HEDIS MY 2026